In the STEP 1 trial DEXA substudy, participants on semaglutide 2.4 mg lost an average of 15 percent of their body weight over 68 weeks
Ozempic often used off-label) Tirzepatide (Zepbound / Mounjaro) a dual GLP-1/GIP agonist that tends to produce even greater weight loss Liraglutide (Saxenda) Originally developed for Type 2 diabetes, these medications received Health Canada approval for chronic weight management in adults with a BMI 30, or BMI 27 with at least one weight-related condition (such as hypertension, dyslipidemia, or obstructive sleep apnea)
If you have had pancreatitis in the past, your doctor may suggest that you avoid taking Semaglutide
When used strategically, GLP-1s during perimenopause and menopause can help you to reach your weight loss goals
BY Jane Kitchen Dr Bren Brown brought her themes of vulnerability and strength to the International Spa Associations Conference & Expo in Las Vegas last week Dr Bren Brown brought her themes of vulnerability and strength to the International Spa Associations Conference & Expo in Las Vegas last week University of Houston research professor and author Dr Bren Brown brought her themes of vulnerability and strength to the International Spa Associations Conference & Expo in Las Vegas last week, delivering the opening speech to an audience of spa and wellness professionals from around the world
